Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

1(20%)

Results Posted

67%(2 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

20%

Ph phase_4

40%

Ph phase_3

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

2(40.0%)

Phase 4Post-market surveillance

2(40.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 32 (40.0%)

Phase 42 (40.0%)

N/A1 (20.0%)

Trials by Status

completed360%

terminated120%

recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

recruitingphase_4

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

NCT05735639

completednot_applicable

The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma

NCT01050153

completedphase_3

Clinical Trials (5)

Showing 5 of 5 trials

NCT05735639Phase 4

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Recruiting

NCT01050153Not Applicable

The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma

Completed

NCT01274637Phase 3

PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot

Completed

NCT00967382Phase 3

TIPPS: Thrombophilia in Pregnancy Prophylaxis Study

Completed

NCT00655122Phase 4

Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study

Terminated

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5